Valenzuela-Faccini, Natalia
Poveda-Henao, Claudia
Flórez-Navas, Catalina
Pérez-Garzón, Michel
Boada-Becerra, Natalia
Mercado-Diaz, Mario
Salcedo, Patricia
Robayo-Amortegui, Henry
Article History
Received: 13 May 2023
Accepted: 6 November 2023
First Online: 19 January 2024
Declarations
:
: The study was approved by the ethics committee of the Fundación Clínica Shaio, Bogotá DC. Colombia (Code # DIB 21–16) and the research committee, carried out according to the modified Helsinki Declaration, waiving informed consent due to the retrospective nature according to local regulations. Following the guidelines of the “Strengthening the Reporting of Observational studies in Epidemiology (STROBE)” for observational cohort studies [CitationRef removed].The primary outcome was to compare the safety variables of the polymethylpentene oxygenator with the polypropylene oxygenator in ECMO therapy during the COVID-19 pandemic. The secondary outcomes were to establish the association of causes of membrane change and to document complications and mortality presented during ECMO support with Inspire membrane compared to conventional membrane.The study was approved by the Institutional Review Board and Ethics Committee of Clínica Shaio.
: Not applicable.
: The authors declare no competing interests.